HC
OLMA icon

Hurley Capital’s Olema Pharmaceuticals OLMA Stock Holding History

Hurley Capital’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$363 Hold
29
– – ﹤0.01% 627
2026
Q1 		$432 Hold
29
– – ﹤0.01% 622
2025
Q4 		$725 Buy
+29
New +$516 ﹤0.01% 533

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Hurley Capital's OLMA Position: Q2 2026 in Review

Hurley Capital held its Olema Pharmaceuticals (OLMA) position steady in Q2 2026 at 29 shares worth $363. The position accounts for ﹤0.01% of the portfolio, ranked #627.

Hurley Capital first reported a position in OLMA in Q4 2025 and has held it in 3 quarters since. The position peaked at $725 in Q4 2025. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Hurley Capital held 29 shares of Olema Pharmaceuticals worth $363 as of Q2 2026.
  • Hurley Capital left its Olema Pharmaceuticals share count unchanged in Q2 2026.
  • Olema Pharmaceuticals made up ﹤0.01% of Hurley Capital's portfolio in Q2 2026, its #627 holding.
  • Hurley Capital first reported a position in Olema Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Hurley Capital's Olema Pharmaceuticals position peaked at $725 in Q4 2025.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Hurley Capital's 13F filing for Q2 2026, filed 10 Aug 2026.